These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
157 related articles for article (PubMed ID: 38280052)
1. Randomized placebo-controlled, double-blind clinical trial of nanoemulsion curcumin in women with aromatase inhibitor-induced arthropathy: an Alliance/NCORP pilot trial. Lustberg M; Fan-Havard P; Wong FL; Hill K; Phelps MA; Herrera KW; Tsai NC; Synold T; Feng Y; Kalu C; Sedrak MS; Yee LD Breast Cancer Res Treat; 2024 May; 205(1):61-73. PubMed ID: 38280052 [TBL] [Abstract][Full Text] [Related]
2. Randomized Multicenter Placebo-Controlled Trial of Omega-3 Fatty Acids for the Control of Aromatase Inhibitor-Induced Musculoskeletal Pain: SWOG S0927. Hershman DL; Unger JM; Crew KD; Awad D; Dakhil SR; Gralow J; Greenlee H; Lew DL; Minasian LM; Till C; Wade JL; Meyskens FL; Moinpour CM J Clin Oncol; 2015 Jun; 33(17):1910-7. PubMed ID: 25940724 [TBL] [Abstract][Full Text] [Related]
3. A randomized, double-blind, placebo-controlled trial of testosterone for treatment of postmenopausal women with aromatase inhibitor-induced arthralgias: Alliance study A221102. Cathcart-Rake E; Novotny P; Leon-Ferre R; Le-Rademacher J; Storrick EM; Adjei AA; Terstriep S; Glaser R; Giuliano A; Mitchell WR; Page S; Austin C; Deming RL; Ferreira MA; Lafky JM; Birrell SN; Loprinzi CL Support Care Cancer; 2021 Jan; 29(1):387-396. PubMed ID: 32372176 [TBL] [Abstract][Full Text] [Related]
4. Randomized placebo-controlled pilot trial of omega 3 fatty acids for prevention of aromatase inhibitor-induced musculoskeletal pain. Lustberg MB; Orchard TS; Reinbolt R; Andridge R; Pan X; Belury M; Cole R; Logan A; Layman R; Ramaswamy B; Wesolowski R; Berger M; Patterson E; Loprinzi C; Shapiro CL; Yee L Breast Cancer Res Treat; 2018 Feb; 167(3):709-718. PubMed ID: 29101597 [TBL] [Abstract][Full Text] [Related]
5. Effect of Acupuncture vs Sham Acupuncture or Waitlist Control on Joint Pain Related to Aromatase Inhibitors Among Women With Early-Stage Breast Cancer: A Randomized Clinical Trial. Hershman DL; Unger JM; Greenlee H; Capodice JL; Lew DL; Darke AK; Kengla AT; Melnik MK; Jorgensen CW; Kreisle WH; Minasian LM; Fisch MJ; Henry NL; Crew KD JAMA; 2018 Jul; 320(2):167-176. PubMed ID: 29998338 [TBL] [Abstract][Full Text] [Related]
6. Randomized phase II placebo-controlled study to evaluate the efficacy of topical pure emu oil for joint pain related to adjuvant aromatase inhibitor use in postmenopausal women with early breast cancer: JUST (Joints Under Study). Chan A; De Boer R; Gan A; Willsher P; Martin R; Zissiadis Y; Miller K; Bauwens A; Hastrich D Support Care Cancer; 2017 Dec; 25(12):3785-3791. PubMed ID: 28691132 [TBL] [Abstract][Full Text] [Related]
7. Effect of whole-body cryotherapy versus placebo cryotherapy on joint pain induced by aromatase inhibitors in women with early stage breast cancer: a randomised clinical trial. Duraes M; Garbay M; Ferrer C; Duflos C; Rathat G BMJ Open; 2023 Dec; 13(12):e071756. PubMed ID: 38070928 [TBL] [Abstract][Full Text] [Related]
8. Randomized exercise trial of aromatase inhibitor-induced arthralgia in breast cancer survivors. Irwin ML; Cartmel B; Gross CP; Ercolano E; Li F; Yao X; Fiellin M; Capozza S; Rothbard M; Zhou Y; Harrigan M; Sanft T; Schmitz K; Neogi T; Hershman D; Ligibel J J Clin Oncol; 2015 Apr; 33(10):1104-11. PubMed ID: 25452437 [TBL] [Abstract][Full Text] [Related]
9. Pilot study of acupuncture for the treatment of joint symptoms related to adjuvant aromatase inhibitor therapy in postmenopausal breast cancer patients. Crew KD; Capodice JL; Greenlee H; Apollo A; Jacobson JS; Raptis G; Blozie K; Sierra A; Hershman DL J Cancer Surviv; 2007 Dec; 1(4):283-91. PubMed ID: 18648963 [TBL] [Abstract][Full Text] [Related]
10. Acupuncture for treatment of arthralgia secondary to aromatase inhibitor therapy in women with early breast cancer: pilot study. Oh B; Kimble B; Costa DS; Davis E; McLean A; Orme K; Beith J Acupunct Med; 2013 Sep; 31(3):264-71. PubMed ID: 23722951 [TBL] [Abstract][Full Text] [Related]
11. Use of letrozole after aromatase inhibitor-based therapy in postmenopausal breast cancer (NRG Oncology/NSABP B-42): a randomised, double-blind, placebo-controlled, phase 3 trial. Mamounas EP; Bandos H; Lembersky BC; Jeong JH; Geyer CE; Rastogi P; Fehrenbacher L; Graham ML; Chia SK; Brufsky AM; Walshe JM; Soori GS; Dakhil SR; Seay TE; Wade JL; McCarron EC; Paik S; Swain SM; Wickerham DL; Wolmark N Lancet Oncol; 2019 Jan; 20(1):88-99. PubMed ID: 30509771 [TBL] [Abstract][Full Text] [Related]
12. Effectiveness, safety, and economic evaluation of adjuvant moxibustion therapy for aromatase inhibitor-induced arthralgia of postmenopausal breast cancer stage I to III patients: Study protocol for a prospective, randomized, assessor-blind, usual-care controlled, parallel-group, pilot clinical trial. Shin S; Jang BH; Park SH; Lee JW; Chae MS; Kim N; Suh HS; Han S; Min SY; Baek SK; Lim YJ; Hwang DS Medicine (Baltimore); 2019 Sep; 98(38):e17260. PubMed ID: 31568000 [TBL] [Abstract][Full Text] [Related]
13. Phase II study of glucosamine with chondroitin on aromatase inhibitor-associated joint symptoms in women with breast cancer. Greenlee H; Crew KD; Shao T; Kranwinkel G; Kalinsky K; Maurer M; Brafman L; Insel B; Tsai WY; Hershman DL Support Care Cancer; 2013 Apr; 21(4):1077-87. PubMed ID: 23111941 [TBL] [Abstract][Full Text] [Related]
14. Omega-3 fatty acid use for obese breast cancer patients with aromatase inhibitor-related arthralgia (SWOG S0927). Shen S; Unger JM; Crew KD; Till C; Greenlee H; Gralow J; Dakhil SR; Minasian LM; Wade JL; Fisch MJ; Henry NL; Hershman DL Breast Cancer Res Treat; 2018 Dec; 172(3):603-610. PubMed ID: 30159789 [TBL] [Abstract][Full Text] [Related]
15. A combination of hydroxytyrosol, omega-3 fatty acids and curcumin improves pain and inflammation among early stage breast cancer patients receiving adjuvant hormonal therapy: results of a pilot study. Martínez N; Herrera M; Frías L; Provencio M; Pérez-Carrión R; Díaz V; Morse M; Crespo MC Clin Transl Oncol; 2019 Apr; 21(4):489-498. PubMed ID: 30293230 [TBL] [Abstract][Full Text] [Related]
16. Adjuvant denosumab in postmenopausal patients with hormone receptor-positive breast cancer (ABCSG-18): disease-free survival results from a randomised, double-blind, placebo-controlled, phase 3 trial. Gnant M; Pfeiler G; Steger GG; Egle D; Greil R; Fitzal F; Wette V; Balic M; Haslbauer F; Melbinger-Zeinitzer E; Bjelic-Radisic V; Jakesz R; Marth C; Sevelda P; Mlineritsch B; Exner R; Fesl C; Frantal S; Singer CF; Lancet Oncol; 2019 Mar; 20(3):339-351. PubMed ID: 30795951 [TBL] [Abstract][Full Text] [Related]
17. Systemic therapies for preventing or treating aromatase inhibitor-induced musculoskeletal symptoms in early breast cancer. Roberts KE; Adsett IT; Rickett K; Conroy SM; Chatfield MD; Woodward NE Cochrane Database Syst Rev; 2022 Jan; 1(1):CD013167. PubMed ID: 35005781 [TBL] [Abstract][Full Text] [Related]
18. Effect of neuromuscular taping on musculoskeletal disorders secondary to the use of aromatase inhibitors in breast cancer survivors: a pragmatic randomised clinical trial. Conejo I; Pajares B; Alba E; Cuesta-Vargas AI BMC Complement Altern Med; 2018 Jun; 18(1):180. PubMed ID: 29890985 [TBL] [Abstract][Full Text] [Related]
19. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas. Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557 [TBL] [Abstract][Full Text] [Related]
20. Tai chi for well-being of breast cancer survivors with aromatase inhibitor-associated arthralgias: a feasibility study. Galantino ML; Callens ML; Cardena GJ; Piela NL; Mao JJ Altern Ther Health Med; 2013; 19(6):38-44. PubMed ID: 24254037 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]